v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 45,170 $ 53,826
Accounts receivable, net 62,383 54,697
Inventories 40,896 26,963
Prepaid expenses 4,452 3,757
Other current assets 14,643 3,674
Total current assets 167,544 142,917
Property and equipment, net 5,046 5,371
Operating lease right-of-use assets 6,436 7,133
Intangible assets, net 45,693 48,040
Goodwill 21,208 21,208
Other assets 2,097 1,199
Total assets 248,024 225,868
Current liabilities    
Accounts payable 44,480 23,360
Accrued expenses 37,724 35,591
Current portion of operating lease liabilities 2,573 2,529
Current portion of contingent royalty obligation payable to Evolus Founders 12,629 12,523
Current portion of contingent milestone payment 1,325 1,302
Total current liabilities 98,731 75,305
Long-term portion of operating lease liabilities 5,487 6,371
Long-term portion of contingent royalty obligation payable to Evolus Founders 16,406 19,659
Long-term debt 156,744 146,096
Long-term portion of contingent milestone payment 1,544 1,515
Deferred tax liability 15 28
Total liabilities 278,927 248,974
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit)    
Preferred stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 0 0
Common stock, $0.00001 par value; 100,000,000 shares authorized; 66,013,698 and 65,008,183 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 1 1
Additional paid-in capital 649,391 638,089
Accumulated other comprehensive loss (529) (156)
Accumulated deficit (679,766) (661,040)
Total stockholders’ equity (deficit) (30,903) (23,106)
Total liabilities and stockholders’ equity (deficit) $ 248,024 $ 225,868